APPLY

Finalists 2026

Meet the 10 projects selected to compete at the Tecnimede Open Innovation Competition 2026 Final Event

Meet the 10 projects selected to compete at the Tecnimede Open Innovation Competition 2026 Final Event.

Biodiffuse

A bio-based alternative to titanium dioxide for pharmaceutical coatings, designed to improve opacity while reducing the need for dyes and synthetic additives.

CELLIMMUNE

A platform that transforms human stromal cells into stable microparticles, enabling targeted and controlled immunomodulation in a ready-to-use format.

Exobiosphere

A platform for developing advanced human disease models in microgravity, enabling more physiologically relevant and high-throughput drug testing in space.

GILDED

A therapeutic platform for type 2 diabetes that delivers specific microRNAs to protect the pancreatic cells responsible for insulin production.

NanoPyl

An antibiotic-free nanotechnology designed to treat H. pylori infections by physically disrupting the bacteria, helping reduce antibiotic resistance while preserving the microbiome.

ohmPRO

A nanoparticle-based therapy with intrinsic anticancer activity, designed to enhance treatment efficacy while reducing the amount of chemotherapy required.

PEPILSKIN

A multifunctional hydrogel for chronic wounds that combines antimicrobial action with tissue regeneration to support faster healing in conditions such as diabetic foot ulcers.

SafeAlleleSCA

WINNER – JORGE RUAS AWARD 2026

An AI-powered platform accelerating drug discovery for brain diseases by predicting blood-brain barrier permeability and reducing failure rates in Central Nervous System drug development.

SilenSCAs

A CRISPR-based gene therapy approach designed to permanently inactivate the disease-causing gene responsible for Machado-Joseph disease.

VTμA Accelerate

A high-throughput tissue-on-chip platform that creates vascularised human microtissues for more predictive, scalable and physiologically relevant drug testing.